圣地亚哥——根据向美国证券交易委员会提交的文件，Gyre Therapeutics, Inc.（纳斯达克股票代码：GYRE）总裁马松江最近出售了部分公司持股。马松江于2025年1月6日和1月7日两天内总共出售了2,216股普通股。根据 InvestingPro 的数据，这些销售发生之际，GYRE股价在过去一周下跌了17%。

Gyre Therapeutics, a biotechnology company, has recently made significant changes to its board of directors and management. The company announced the appointment of Ping Zhang as the lead independent ...

Earlier in his career, Dr. West-Sells worked with major mining companies such as BHP, Placer Dome, and Barrick in senior technical roles focused on Research & Development and Project Development. He ...

Gyre Therapeutics ( (GYRE) ) has provided an announcement.

Gyre Therapeutics (GYRE) announced the appointment of Ping Zhang to its Board of Directors as the lead independent director of the Board and a ...

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic ...

President Songjiang Ma sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $12.50, for a total value of ...

State Street Corp increased its stake in shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE – Free Report) by 8.8% in the 3rd ...